Dr. Reddy's Laboratories Limited reported INR 325.5B of revenue over the trailing twelve months, +17% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: INR 325.5B (to FY2025). Net income: INR 56.5B, trailing twelve months to FY2025. Free cash flow: INR 18.9B, trailing twelve months to FY2025. Operating margin: 22%, trailing twelve months to FY2025.

RDYDr. Reddy's Laboratories Limited

Healthcare

$12.46-16% 1Y

$12.46

$11.4052 weeks$15.25

RDY as reported

Dr. Reddy's Laboratories Limited reported INR 325.5B of revenue over the trailing twelve months, +17% on the year before. 10 reported series are charted on this page, each one as filed.

INR 325.5B

Revenue, trailing twelve months · to FY2025 · +17% against the twelve months before

Net income: INR 56.5B
Net income · +1.5% year on year · trailing twelve months to FY2025
Free cash flow: INR 18.9B
Free cash flow · −35% year on year · trailing twelve months to FY2025
Operating margin: 22%
Operating margin · trailing twelve months to FY2025

Details›

Every series Ryufin has for RDY, trailing twelve months
Series	Latest	Year on year	As of
Revenue	INR 325.5B	+17%	FY2025
Net income	INR 56.5B	+1.5%	FY2025
EPS	INR 67.78	+1.5%	FY2025
Gross margin	58%	n/a	FY2025
Operating margin	22%	n/a	FY2025
Net margin	17%	n/a	FY2025
ROE	17%	n/a	FY2025
ROA	11%	n/a	FY2025
ROIC	15%	n/a	FY2025
Free cash flow	INR 18.9B	−35%	FY2025

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.